Avrio Biopharmaceuticals LLC - Irvine, California 92618

Avrio Biopharmaceuticals LLC is categorized under in Irvine, CA .

Business Name: Avrio Biopharmaceuticals LLC
Contact Person: Assad Kazeminy, Chief Executive Officer
Address: 4 Chrysler, Irvine, California 92618
Phone Number: (949) 462-0814
Website Address: irvinepharma.com
Annual Revenue (USD): $5.000.000 to $9.999.999
Founding Year: 2008
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B & B2C
Business Category:
SIC Code: 2834
NAICS Code: 3254120
Share This Business:
Related Businesses: Cdp International - Irvine, CA 92618
Valley Forge Pharmaceutic - Irvine, CA 92618
Earth Pharmaceuticals - Irvine, CA 92618
Regeneca Inc - Irvine, CA 92618
Nexell Therapeutics Inc - Irvine, CA 92618
Biofem Inc - Irvine, CA 92618
Neojb LLC - Irvine, CA 92618
DiscoverIT Solutions Inc. - Irvine, CA 92618
Vitae Pharmaceuticals Inc - Irvine, CA 92618
Abbott/Stegman/Ppd - Irvine, CA 92618
Ista Pharmaceuticals Inc - Irvine, CA 92618
Stason Pharmaceutical Inc - Irvine, CA 92618
Anchen Pharmaceuticals - Irvine, CA 92618
Stason Pharmaceuticals - Irvine, CA 92618
Gensia Laboratories - Irvine, CA 92618
Boehringer Mannheim Pharmaceut - Irvine, CA 92618

The company Avrio Biopharmaceuticals LLC provides BOTH services in the form of from its single location in California. 1 to 4 employees work for Avrio Biopharmaceuticals LLC, and the business now earns $5.000.000 to $9.999.999 per annum.

Avrio Biopharmaceuticals LLC was launched in 2008 and is classified under SIC code and category 2834 , and NAICS number and grouping 3254120 . To contact Avrio Biopharmaceuticals LLC, please call Assad Kazeminy, Chief Executive Officer with the phone number (949) 462-0814 or visit its single location at 4 Chrysler in Irvine, California 92618.

The location of the single location can also be found using the coordinates 33.65018,-117.71171. Read more details about this business on the webpage irvinepharma.com or follow the company’s social media accounts, on Twitter and on Facebook.